DE LUCA, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
EU - Europa 175.771
NA - Nord America 10.038
AS - Asia 4.128
SA - Sud America 715
Continente sconosciuto - Info sul continente non disponibili 409
AF - Africa 126
OC - Oceania 13
Totale 191.200
Nazione #
IT - Italia 173.241
US - Stati Uniti d'America 9.807
SG - Singapore 1.601
CN - Cina 1.344
BR - Brasile 567
SE - Svezia 474
UA - Ucraina 472
VN - Vietnam 393
DE - Germania 368
FI - Finlandia 249
NL - Olanda 237
GB - Regno Unito 213
FR - Francia 199
HK - Hong Kong 161
CA - Canada 123
IN - India 115
BD - Bangladesh 103
KR - Corea 80
AR - Argentina 51
JP - Giappone 50
RU - Federazione Russa 47
PL - Polonia 46
MX - Messico 38
ES - Italia 37
IQ - Iraq 34
MA - Marocco 31
ZA - Sudafrica 30
TR - Turchia 27
PK - Pakistan 26
CH - Svizzera 25
AT - Austria 24
BE - Belgio 23
ID - Indonesia 23
CO - Colombia 21
IL - Israele 20
IE - Irlanda 19
CZ - Repubblica Ceca 18
SA - Arabia Saudita 18
EC - Ecuador 17
UZ - Uzbekistan 16
VE - Venezuela 16
CL - Cile 15
JM - Giamaica 15
KE - Kenya 14
AU - Australia 13
PH - Filippine 12
RO - Romania 12
TW - Taiwan 12
DZ - Algeria 10
EG - Egitto 10
MY - Malesia 10
IR - Iran 9
JO - Giordania 9
LT - Lituania 9
PY - Paraguay 9
CR - Costa Rica 8
PT - Portogallo 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EU - Europa 7
KZ - Kazakistan 7
PE - Perù 7
RS - Serbia 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HU - Ungheria 6
LV - Lettonia 6
NI - Nicaragua 6
SV - El Salvador 6
CW - ???statistics.table.value.countryCode.CW??? 5
CY - Cipro 5
GT - Guatemala 5
KG - Kirghizistan 5
LB - Libano 5
PA - Panama 5
SC - Seychelles 5
AM - Armenia 4
EE - Estonia 4
NP - Nepal 4
PS - Palestinian Territory 4
SN - Senegal 4
BY - Bielorussia 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
GP - Guadalupe 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
Totale 190.776
Città #
Cagliari 167.887
Uta 3.503
Ashburn 1.332
Singapore 812
Fairfield 711
San Jose 625
Woodbridge 504
Dallas 450
Chandler 424
Houston 353
Boardman 330
Beijing 292
Nyköping 288
Wilmington 269
Ann Arbor 267
Jacksonville 260
Dearborn 249
Seattle 228
Cambridge 225
Council Bluffs 186
Los Angeles 185
Milan 169
Santa Clara 165
Helsinki 162
New York 158
Hong Kong 144
The Dalles 137
Ho Chi Minh City 128
Rome 102
Nanjing 101
Shanghai 101
Boston 97
Lauterbourg 94
Hefei 91
Hanoi 77
Buffalo 73
Seoul 70
Munich 67
Orem 67
São Paulo 63
Frankfurt am Main 51
Chicago 45
Dong Ket 44
Atlanta 43
Guangzhou 42
Toronto 42
Phoenix 39
San Francisco 36
Tokyo 36
Chennai 32
San Diego 32
Florence 31
Nanchang 31
Brooklyn 30
London 30
Montreal 30
Changsha 25
Columbus 25
Shenyang 25
Denver 24
Hebei 24
Princeton 24
Jiaxing 23
Redwood City 23
Tianjin 23
Washington 23
Casablanca 22
Verona 22
Warsaw 22
Norwalk 21
Nuremberg 21
Amsterdam 20
Bologna 20
Naples 19
Reggio Emilia 19
Redondo Beach 18
Stockholm 17
Mexico City 16
Mountain View 16
Orange 16
Sassari 16
Villafranca di Verona 16
Wuhan 16
Belo Horizonte 15
Brasília 15
Da Nang 15
Jinan 15
Paris 15
Philadelphia 15
Turin 15
Düsseldorf 14
Johannesburg 14
Kunming 14
Manchester 14
San Mateo 14
Vienna 14
Zhengzhou 14
Brno 13
Brussels 13
Charlotte 13
Totale 182.838
Nome #
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.397
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 4.173
Caffeine and the brain: an overview 3.754
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.640
Dopamine restores limbic memory loss, dendritic spine structure, and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats 3.431
Endocannabinoid 2-arachidonoylglycerol self-administration by Sprague-Dawley rats and stimulation of in vivo dopamine transmission in the nucleus accumbens shell 3.289
Metronidazole prodrugs: Synthesis, physicochemical properties, stability, and ex vivo release studies 3.275
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.198
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration? 3.037
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics 2.960
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.805
Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. 2.739
LC-MS-MS determination of rotenone, deguelin, and rotenolone in human serum 2.735
Role of dopamine D(1) receptors in caffeine-mediated ERK phosphorylation in the rat brain 2.724
Serotonergic signaling controls input-specific synaptic plasticity at striatal circuits 2.724
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: jwh-018 2.662
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.651
Loren Parsons' contribution to addiction neurobiology 2.580
Cannabis; epidemiological, neurobiological and psychopathological issues: an update 2.529
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.489
DOPAMINE MICRODIALYSIS IN THEACCUMBENS SHELL/COREAND PREFRONTAL COTEX AFTER ACUTE ANTIPSYCHOTICS 2.456
OX26 MAB IMMUNOLIPOSOMES FOR THE DELIVERY OF SENKTIDE TO THE BRAIN 2.416
Lesion of medial prefrontal dopamine terminals abolishes habituation of accumbens shell dopamine responsiveness to taste stimuli 2.367
Cannabinoidi sintetici 2.0: ecco cosa si cela all’interno delle spice drugs 2.347
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 2.345
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia 2.336
Sales and advertising channels of new psychoactive substances (NPS): Internet, social networks, and smartphone apps 2.307
5HT/DA system interactions in the reinforcing properties of psychostimulants: role of 5-HT6 receptors 2.306
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.269
Cannabinoids and drug addiction 2.258
Neuropharmacology of New psychoactive substances (NPS): Focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants 2.219
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.166
null 2.160
Influence of morphine sensitization on the responsiveness of mesolimbic and mesocortical dopamine transmission to appetitive and aversive gustatory stimuli 2.110
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 2.087
Is there a teratogenicity risk associated with cannabis and synthetic cannabimimetics' ('Spice') intake? 2.070
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.044
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 2.042
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 1.997
Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe 1.967
Studio degli effetti acuti e cronici e delle proprietà d'abuso del cannabinoide sintetico JWH-018: Un approccio multidisciplinare 1.884
Erratum to: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment (Nature Communications, (2018), 9, 1, (2265), 10.1038/s41467-018-04711-w) 1.883
4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study 1.876
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.874
Responsiveness of nucleus accumbens and prefrontal cortex dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.846
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.845
Brain-wide mapping of endogenous serotonergic transmission via chemogenetic fMRI 1.781
Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences 1.772
Effect of mPFC 6-OHDA lesions in the NAc Shell DA response to appetitive stimuli 1.769
Effect of JWH-250, JWH-073 and their interaction on "tetrad", sensorimotor, neurological and neurochemical responses in mice 1.761
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 1.744
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48: Behavioral, neurochemical, and dopamine transporter scan imaging studies in mice 1.740
Behavioural and neurochemical rewarding properties of the endocannabinoid 2-arachidonylglycerol 1.729
Effect of medial prefrontal cortex 6-hydroxy-dopamine on the nucleus accumbens dopamine responsiveness to appetitive stimuli 1.728
Cannabis come sostanza d'abuso 1.638
Habituation of the responsiveness of mesolimbic and mesocortical dopamine transmission to taste stimuli 1.631
Possible role of 5-HT6 receptors in addictions - Possibile ruolo dei recettori 5-HT6 nelle dipendenze 1.609
Interaction between 5-HT and DA in relation to the treatment of psychostimulant dependence 1.608
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.601
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.581
Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue? 1.555
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 1.531
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses 1.436
JWH-018: a cannabinoid compound of Spice drugs stimulates dopamine transmission in the nucleus accumbens shell 1.415
Pharmacological and behavioral effects of the synthetic cannabinoid akb48 in rats 1.395
Taste novelty and dopamine in Food Neophobia Behavioral and Biological Influences 1.368
Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment 1.361
Strategies of intervention to limit the novel synthetic opioids (NSO) escalation in Europe 1.334
Typical and atypical antipsychotics: effects on motor behavior and differential responsiveness of shell/core/prefrontal cortex dopamine transmission 1.330
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.309
Caffeine sensitization and cross-sensitization with amphetamine: association to post-synaptic changes in rat striatal neurons 1.282
Editorial: Deconstructing the influence of genetic and age vulnerability to psychiatric disorders 1.254
Activation of PPAR gamma by the anti-diabetic agent pioglitazone reduces opioid reinforcement and opioid- induced activation of the mesolimbic dopamine system 1.250
Caffeine and accumbens shell dopamine 1.248
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA 1.218
Caffeine and Accumbens shell dopamine 1.203
null 1.194
Responsiveness of n. accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.139
Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus 1.138
Responsiveness of N. Accumbens dopamine transmission to appetitive and aversive gustatory stimuli in rats sensitized to morphine 1.108
Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex 1.086
Human neuronal cell lines as an in vitro toxicological tool for the evaluation of novel psychoactive substances 1.074
Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats 1.066
BEHAVIORAL AND BIOCHEMICAL CHARACTERIZATION OF THE ST1936, A NEW 5-HT6 AGONIST 1.060
CAFFEINE SESITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS 1.059
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.058
CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURON 1.055
New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT 2 receptors in pharmacological and behavioral effects in the rat 1.036
Differential effects of natural and pharmacological rewards on dopamine transmission in the nucleus accumbens shell and core and in the prefrontal cortex 1.033
Responsiveness of mesolimbic and mesocortical dopamine transmission to bitter/aversive and sweet/palatable gustatory stimuli in fed ad libitum rats. 987
Differential responsiveness of shell/core/prefrontal dopamine transmission to taste stimuli 952
Dopamine Transmission and aversive motivation 916
Differential effect of morphine-conditioned and food-conditioned stimuli on dopamine release in the nucleus accumbens shell and core and in the prefrontal cortex 909
Dopamine and drug addiction: the nucleus accumbens shell connection 781
Role of metabolism in rotenone neurotoxicity 775
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects 774
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists 742
Characterization of the in vivo efficacy on dopaminergic and noradrenergic neurotransmission of a novel NK3 receptor antagonist: RO5313520. 716
Adolescent self-administration of the synthetic cannabinoid receptor agonist JWH-018 induces neurobiological and behavioral alterations in adult male mice 714
METRONIDAZOLE TWO AMIDE PRODRUGS: SYNTHESIS, PSYCHOCHEMICAL PROPERTIES, STABILITY AND EX VIVO RELEASE STUDIES 686
Totale 185.508
Categoria #
all - tutte 241.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 241.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.137 0 0 0 0 753 489 452 601 954 1.136 937 815
2022/202314.739 1.263 1.932 1.861 1.010 876 1.788 836 1.078 1.001 990 1.417 687
2023/202415.805 683 655 561 860 1.404 2.170 2.365 2.183 765 1.009 1.597 1.553
2024/202521.925 3.522 4.047 4.220 2.877 2.073 1.476 2.037 206 381 312 362 412
2025/20269.402 623 501 946 793 727 609 1.604 518 598 1.721 445 317
2026/20272.876 461 549 794 918 154 0 0 0 0 0 0 0
Totale 191.200